{"id":11511,"date":"2024-06-20T16:40:51","date_gmt":"2024-06-20T16:40:51","guid":{"rendered":"https:\/\/www.healthnews.ie\/?p=11511"},"modified":"2024-06-24T08:02:38","modified_gmt":"2024-06-24T08:02:38","slug":"whats-needed-to-safeguard-stable-medicines-development","status":"publish","type":"post","link":"https:\/\/www.healthnews.ie\/life-sciences\/whats-needed-to-safeguard-stable-medicines-development\/","title":{"rendered":"What\u2019s needed to safeguard stable medicines development"},"content":{"rendered":"\n<div style=\"background-color:#f2f2f2;color:#32373c\" class=\"wp-block-atomic-blocks-ab-profile-box round ab-has-avatar ab-font-size-14 ab-block-profile ab-profile-columns\"><div class=\"ab-profile-column ab-profile-avatar-wrap\"><div class=\"ab-profile-image-wrap\"><figure class=\"ab-profile-image-square\"><img loading=\"lazy\" decoding=\"async\" width=\"250\" height=\"250\" class=\"ab-profile-avatar wp-image-11512\" src=\"https:\/\/s3.eu-north-1.amazonaws.com\/cdn-site.mediaplanet.com\/app\/uploads\/sites\/94\/2024\/06\/07205750\/Eimear-OLeary-Headshot.jpg\" alt=\"\" srcset=\"https:\/\/s3.eu-north-1.amazonaws.com\/cdn-site.mediaplanet.com\/app\/uploads\/sites\/94\/2024\/06\/07205750\/Eimear-OLeary-Headshot.jpg 250w, https:\/\/s3.eu-north-1.amazonaws.com\/cdn-site.mediaplanet.com\/app\/uploads\/sites\/94\/2024\/06\/07205750\/Eimear-OLeary-Headshot-125x125.jpg 125w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/figure><\/div><\/div><div class=\"ab-profile-column ab-profile-content-wrap\"><h2 class=\"ab-profile-name\" style=\"color:#32373c\">Eimear O&#8217;Leary<\/h2><p class=\"ab-profile-title\" style=\"color:#32373c\">Director of Communications and Advocacy, IPHA<\/p><div class=\"ab-profile-text\"><\/div><ul class=\"ab-social-links\"><\/ul><\/div><\/div>\n\n\n\n<p><em>Medicines allow people to live longer, healthier lives. They prevent chronic illnesses, improve survival rates for many diseases, combat obesity and improve mental health.<\/em><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p>Medicines bring additional health benefits by releasing other healthcare resources, which helps with hospital waiting lists and overcrowded GP clinics. However, for this to happen, a medicine needs to travel a long road \u2014 from bench to bedside.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-medicines-r-amp-d-requirements\"><strong>Medicines R&amp;D requirements<\/strong><\/h2>\n\n\n\n<p>The research, development and approval process takes between 10 and 15 years, costing about \u20ac2.13 billion. For innovation and medicines development to flourish, predictability and stability within the biopharmaceutical research environment are required.<\/p>\n\n\n\n<p>Central to this is intellectual property (IP) rights, which protect innovative companies\u2019 investment and incentivise the development of new medicines. One such incentive is Regulatory Data Protection (RDP), currently the source of much debate arising from the European Commission\u2019s proposal to cut the current baseline period of RDP from eight years to six years, with conditions on how to achieve the further two years.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-rdp-enables-pharmaceutical-innovation\"><strong>RDP enables pharmaceutical innovation<\/strong><\/h2>\n\n\n\n<p>Industry shares the goals of the European Commission, as outlined in the EU Pharmaceutical Legislative package, of providing equitable access to medicines throughout EU Member States while ensuring that Europe can be a world leader in medical innovation. However, cutting the period of RDP has the potential to cause a loss of competitiveness and lead to fewer new medicines being available to Europeans.<\/p>\n\n\n\n<p>R&amp;D is already leaving European shores. In the 1990s, half of all new treatments originated in Europe, that figure is now just one in five. In 2002, the US spent \u20ac2 billion more than Europe on pharmaceutical R&amp;D. Today, the US is spending \u20ac25 billion more. This means fewer opportunities to participate in clinical trials; longer delays in accessing innovative medicines; and a loss of know-how.<\/p>\n\n\n\n<p>Stable and appropriate RDP is key to long-term investment in medicines development. A robust and innovative EU pharmaceutical industry is essential for Europe&#8217;s ambitions to combat cancer, address public health challenges (like antimicrobial resistance and Alzheimer&#8217;s) and prepare for future pandemics.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medicines allow people to live longer, healthier lives. They prevent chronic illnesses, improve survival rates for many diseases, combat obesity and improve mental health. Medicines bring additional health benefits by releasing other healthcare resources, which helps with hospital waiting lists and overcrowded GP clinics. However, for this to happen, a medicine needs to travel a &hellip; <a href=\"https:\/\/www.healthnews.ie\/life-sciences\/whats-needed-to-safeguard-stable-medicines-development\/\">Continued<\/a><\/p>\n","protected":false},"author":23,"featured_media":11513,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2216],"tags":[5918],"class_list":["post-11511","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-sciences","tag-life-sciences-q2-2024"],"acf":[],"featured_image_src":"https:\/\/s3.eu-north-1.amazonaws.com\/cdn-site.mediaplanet.com\/app\/uploads\/sites\/94\/2024\/06\/07205749\/AdobeStock_809423733-600x400.jpg","featured_image_src_square":"https:\/\/s3.eu-north-1.amazonaws.com\/cdn-site.mediaplanet.com\/app\/uploads\/sites\/94\/2024\/06\/07205749\/AdobeStock_809423733-600x600.jpg","author_info":{"display_name":"Your Future Career","author_link":"https:\/\/www.healthnews.ie\/author\/harveyodonnell\/"},"vicky_index_order":"","_links":{"self":[{"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/posts\/11511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/comments?post=11511"}],"version-history":[{"count":2,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/posts\/11511\/revisions"}],"predecessor-version":[{"id":11599,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/posts\/11511\/revisions\/11599"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/media\/11513"}],"wp:attachment":[{"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/media?parent=11511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/categories?post=11511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/tags?post=11511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}